Tags : Enter

Pharma

Innovent and Shenogen Enter into a Collaboration to Evaluate the

Shots: The companies enter into an agreement to evaluate the combination of Innovent’s Tyvyt with Shenogen’s SNG1005 for the patients with advanced cancer  Shenogen has in-licensed SNG1005 and has exclusive rights to develop & commercialize it in Greater China. SNG1005 has completed multiple P-II trials in the US with an approved NMPA’s IND application of […]Read More

DigiHealth

MannKind Enter into an Agreement with One Drop to Combine

Shots: MannKind and One Drop collaborate to integrate MannKind’s BluHale, a Bluetooth connected accessory attached to Afrezza inhaler in to the One drop platform. In H1’19, One drop announced clinical study results assessing Afrezza with One Drop, which demonstrated improvement in A1C levels The focus of the agreement is to provide seamless experience for patients […]Read More